@adamfeuersteinFeb 5, 2026 · 7:16 PM@NicholasChoupak 100% agree with you. It's a very odd strategy for $EYPT to take. Duker should be cheering for $OCUL, not trash talking.Open on X →
@adamfeuersteinFeb 5, 2026 · 6:51 PMA rival goes after Ocular Therapeutix $OCUL on eve of pivotal readout on eye treatment Eyepoint Pharma $EYPT CEO said to have trash-talked Ocular’s drug at a recent investor conference https://t.co/LSUm4WPWKAOpen on X →
